A chemistry wiki to facilitate and enhance compound design in drug discovery

Drug Discovery Today

Volumn 18, Issue 3-4, 2013, Pages 141-147

  Robb, Graeme R ^a   McKerrecher, Darren ^a   Newcombe, Nicholas J ^a   Waring, Mike J ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZETIDINE;

COMPUTER PROGRAM; DECISION MAKING; DRUG ANALYSIS; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; INFORMATION SCIENCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SOCIAL MEDIA; SOCIAL NETWORK; WEB BROWSER; WORKFLOW;

DRUG DESIGN; INTERNET; SOFTWARE;

EID: 84873087379     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.09.002     Document Type: Review

References (25)

1. K.L.M. Drew Size estimation of chemical space: how big is it? J. Pharm. Pharmacol. 64 2012 490 495
2. D.F. Horrobin Realism in drug discovery-could Cassandra be right? Nat. Biotechnol. 19 2001 1099 1100
3. R. Macarron Impact of high-throughput screening in biomedical research Nat. Rev. Drug Discov. 10 2011 188 195
4. T.T. Ashburn, and K.B. Thor Drug repositioning: identifying and developing new uses for existing drugs Nat. Rev. Drug Discov. 3 2004 673 683
5. S.M. Paul How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
6. A.T. Plowright Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle Drug Discov. Today 17 2012 56 62
7. S. Andersson Making medicinal chemistry more effective-application of Lean Sigma to improve processes, speed and quality Drug Discov. Today 14 2009 598 604
8. C. Johnstone Creativity, innovation and lean sigma: a controversial combination? Drug Discov. Today 16 2011 50 57
9. G. Festel Outsourcing chemical synthesis in the drug discovery process Drug Discov. Today 16 2011 237 243
10. Subramaniam, S. and Dugar, S. (2012) Outsourcing drug discovery to India and China: from surviving to thriving. Drug Discov. Today, http://dx.doi.org/10. 1016/j.drudis.2012.04.005 (http://www.drugdiscoverytoday.com).
11. M.D. Brodney Project-focused activity and knowledge tracker: a unified data analysis, collaboration, and workflow tool for medicinal chemistry Project Teams J. Chem. Inf. Model. 49 2009 2639 2649
12. M. Lee DEGAS: sharing and tracking target compound ideas with external collaborators J. Chem. Inf. Model. 52 2012 278 284
13. T. Sander OSIRIS, an entirely in-house developed drug discovery informatics system J. Chem. Inf. Model. 49 2009 232 246
14. M. Hohman Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery Drug Discov. Today 14 2009 261 270
15. A.J. Williams Internet-based tools for communication and collaboration in chemistry Drug Discov. Today 13 2008 502 506
16. A. Mayweg ROCK: the Roche medicinal chemistry knowledge application-design, use and impact Drug Discov. Today 16 2011 691 696
17. D.R. Cheshire How well do medicinal chemists learn from experience? Drug Discov. Today 16 2011 817 821
18. T. O'Reilly What is Web2.0: design patterns and business models for the next generation of software Commun. Strat. 65 2007 17 37
19. G.R. Robb Hypothesis-driven drug design using wiki-based collaborative tools UK-QSAR and ChemoInformatics Spring Meeting 2009
20. S.L. Rodgers Predictivity of simulated ADME AutoQSAR models over time Mol. Informatics 30 2011 256 266
21. H. van de Waterbeemd Improving compound quality through in vitro and in silico physicochemical profiling Chem. Biodivers. 6 2009 1760 1766
22. S.L. Rodgers QSAR modeling using automatically updating correction libraries: application to a human plasma protein binding model J. Chem. Inf. Model. 47 2007 2401 2407
23. J.D. Hughes Physiochemical drug properties associated with in vivo toxicological outcomes Bioorg. Med. Chem. Lett. 18 2008 4872 4875
24. P.D. Leeson, and B. Springthorpe The influence of drug-like concepts on decision-making in medicinal chemistry Nat. Rev. Drug Discov. 6 2007 881 890
25. M.J. Waring Matrix-based multiparameter optimisation of glucokinase activators: the discovery of AZD1092 MedChemComm 2 2011 775 779